Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Effectiveness of a Treat-to-target Clinic Led by a Nurse Consultants

The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2011 by Asia Diabetes Foundation.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Asia Diabetes Foundation
ClinicalTrials.gov Identifier:
NCT01348867
First received: May 4, 2011
Last updated: May 5, 2011
Last verified: May 2011
  Purpose

The investigators hypothesize a diabetes nurse consultant led team with particular emphasis on compliance and attainment of treatment targets in Type 2 diabetic patients will achieve metabolic control, improve clinical outcomes and levels of self efficacy compared to usual clinic-based care.


Condition Intervention
Diabetes
Other: Structured care led by a nurse consultant

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Supportive Care
Official Title: A Randomised Study to Evaluate the Effectiveness of a Treat-to-target Clinic Led by a Nurse Consultant in Managing Patients With Type 2 Diabetes in Hong Kong

Resource links provided by NLM:


Further study details as provided by Asia Diabetes Foundation:

Primary Outcome Measures:
  • To assess the effectiveness of the nurse consultant led clinic in improving glycemic parameters in patients with type 2 diabetes [ Time Frame: 12 months ] [ Designated as safety issue: No ]
    Metabolic parameters such as HbA1c, blood pressure, lipid profile, body mass index (BMI) etc, will measured at specific time points throughout the study


Secondary Outcome Measures:
  • To assess the any changes in diabetic knowledge, behaviours and level self-efficacy of the participants as compared to the control patients [ Time Frame: 12 months ] [ Designated as safety issue: No ]
    The cognitive psychosocial-behavior assessment will include using the Summary of Diabetes Self- Care Activities (SDSCA), Diabetes Empowerment Scale (DES), Depression Anxiety Stress Scale-21 (DASS21), General Health Questionnaire (GHQ12).

  • A comparison of the patients' utility of healthcare services [ Time Frame: 12 months ] [ Designated as safety issue: No ]
    The number of hospital admissions, total number of days stay in hospital, number of attendances at Accident and Emergency department will be explored and compared for all patients.


Estimated Enrollment: 240
Study Start Date: June 2010
Estimated Study Completion Date: June 2012
Estimated Primary Completion Date: January 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
No Intervention: Usual Care
These 120 controls will undergo a comprehensive assessment at baseline then again at 12 months, which is similar to the intervention group. However, in between these 2 time points the 'control' patients will receive usual care and hence will not be monitored under the structured care protocol by a diabetes nurse consultant led team.
Experimental: Structured Care

120 patients will be randomised to the structured care group, and these patients will receive repeated follow-ups and contact with the structured care team in between the two comprehensive assessments at week 0 and week 52.

Patients will be seen by Diabetes Nurse Consultant at week 0, 6, 12, 24 38 during the year. At each visit, clinical and laboratory measurements will be performed; treatment compliance and self care will be assessed and medications will be adjusted to optimise metabolic and cardiovascular risk factors control.

Patients will be seen by the doctors in their clinic follow up at week 0, 24 and 52.

Technical service assistance will telephone patient at week 18, 30 and 44 to reinforce patient to take medications, attend clinical follow up.

Other: Structured care led by a nurse consultant

For the intervention group, patients will be followed up according to the following protocol. The structured care team consists of:

i) Diabetes Nurse Consultant to reinforce compliance; educate patients on insulin injection techniques and reinforce self-care including self blood glucose monitoring and lifestyle interventions, titration of medication.

ii) Technical Service Assistance to remind patients to take medications and/or give insulin injection, monitor blood glucose as prescribed, attend their next clinic appointment, encourage patients to report all side effects, self initiated change in regimen or concerns to diabetes nurse consultant and/or their doctors at the next follow up visit.


Detailed Description:

Diabetes patients consume over 10% of health care costs in most developed countries. Over 80% of these resources are used to treat diabetic complications and late stage diseases. In Hong Kong, the prevalence of diabetes was reported to be 10%. Over 30% of patients admitted to the medical wards in Hong Kong's public hospitals have diabetes, mainly due to cardiovascular and renal complications. The number of patients receiving renal replacement therapy has increased by 50% in the last 5 years but the number of patients with end stage renal disease due to diabetes has doubled. Between 10% and 15% of patients attending medical clinics in local public hospitals either receive insulin or anti-diabetic drugs. Local published data show that 3-10% of diabetic patients died or developed clinical endpoints yearly.

There are now overwhelming evidence supporting the beneficial effects of optimal control of cardiovascular risk factors on clinical outcomes in diabetic patients. However, there are few studies to examine the most effective way to translate these evidence collected in closely monitored clinical trials situations into daily clinical practice. Against this background, the investigators hypothesize that disease management using a team approach to implement a structured care model in daily clinical practice will improve the clinical outcomes in high risk Type 2 diabetic patients compared to usual clinic-based care with no specific built in protocol and/or monitoring mechanism to ensure its effective implementation. The nurse consultant led clinics will use a structured protocol with particular emphasis on periodic monitoring, treating to target and reinforcing patient adherence.

In light of the size of diabetes epidemic, the constraints of finite resources and the need for equity, the investigators propose the results from this randomized study will provide information to health care policy makers regarding the effectiveness of diabetes nurse consultant led clinics in managing diabetic patients.

  Eligibility

Ages Eligible for Study:   18 Years to 75 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Type 2 diabetic patients
  • Aged between 18 and 75 years (inclusive)
  • HbA1c >8%
  • Chinese in ethnicity
  • patients under the care of clinicians who aimed the treatment targets of their patients as HbA1c <7%, BP <130/80 mmHg, and LDL-C <2.6 mmol/L

Exclusion Criteria:

  • patients with clinically unstable psychiatric illnesses
  • patients with terminal malignancy or other life-threatening diseases with less than 3-month expected survival
  • patients who speak non-Cantonese dialect or a different language or have conditions that prevent effective face-to-face or telephone communications eg. Patients who are deaf or mute
  • patients who live in nursing home with supervised treatment
  • patients who are not available via telephone contact
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01348867

Contacts
Contact: Rebecca Wong wongymr@ha.org.hk

Locations
Hong Kong
Diabetes & Endocrine Centre, Prince of Wales Hospital Recruiting
Shatin, New Territories, Hong Kong
Contact: Rebecca Wong       wongymr@ha.org.hk   
Principal Investigator: Rebecca Wong         
Sponsors and Collaborators
Asia Diabetes Foundation
Investigators
Principal Investigator: Rebecca Wong Prince of Wales Hospital, Shatin, Hong Kong
  More Information

Additional Information:
No publications provided

Responsible Party: Dr. Rebecca Wong, Department of Therapeutics, Prince of Wales Hospital
ClinicalTrials.gov Identifier: NCT01348867     History of Changes
Other Study ID Numbers: CRE-2009-394
Study First Received: May 4, 2011
Last Updated: May 5, 2011
Health Authority: Hong Kong: Joint CUHK-NTEC Clinical Research Ethics Committee

Keywords provided by Asia Diabetes Foundation:
Diabetes
Structured Care

Additional relevant MeSH terms:
Diabetes Mellitus
Endocrine System Diseases
Glucose Metabolism Disorders
Metabolic Diseases

ClinicalTrials.gov processed this record on November 20, 2014